Dr. Robert Huizinga
PhD, RN, CNeph(C)
Interim Chief Executive Officer
Dr. Huizinga comes to Kane having served as Executive Vice-President of Aurinia Pharmaceuticals Inc. At Aurinia, he led the clinical development of voclosporin over 17 years, which was FDA approved and achieved first-year sales of US$100 million. Prior to that, Dr. Huizinga was the Vice President of Clinical Affairs for Isotechnika Inc., and a clinical investigator at the University of Alberta. Dr. Huizinga holds a PhD in Organizational Leadership, and a Masters of Medical Science in Clinical Epidemiology, and continues to hold his Registered Nursing status.
Ray Dupuis
MBA, BSc, BA, CPA
Chief Financial Officer
Ray Dupuis brings more than 25 years of financial leadership experience across a broad range of industries, including 15 years with a rapidly growing public biotechnology company. He is a Chartered Professional Accountant (CPA) and holds a BSc in Biology, a Bachelor of Arts in Administrative Studies, and an MBA in Finance.
Lori Christofalos
BSc
Chief Quality Officer
Ms. Christofalos provides over 30 years of leadership experience in Quality, Compliance, Validation and Regulatory Affairs in the regulated pharmaceutical and medical device industries, in both domestic and international domains. Ms. Christofalos has served on life sciences industry boards, and holds a BSc (Chemistry) and a diploma in Bioengineering-Chemical Technology.
S. Kay Watkins Weaver
BA, ABWM, CM-AMA
Vice President of Business Development, US
Kay brings more than 20 years of healthcare leadership experience in advanced wound care, commercialization, reimbursement, and market access. Her career includes launching the VAC® negative pressure wound therapy system and securing Medicare coding, coverage, and reimbursement approvals that expanded patient access to innovative wound care technologies. Prior to joining Kane Biotech, she held senior leadership positions focused on sales growth, market development, and strategic partnerships across health systems, long-term care organizations, and national home health providers. Kay studied psychology at Cleveland State University.
Patti Burke-Martin
BScN
Vice President of Business Development, Canada
Patti Burke-Martin brings nearly 30 years of leadership experience in the Canadian healthcare industry, specializing in advanced wound care, medical technologies, and commercialization. Beginning her medical device career at KCI Medical, she has held leadership positions across the wound care industry, building strong relationships with clinical leaders, healthcare organizations, and industry partners throughout Canada and the United States. Her background in nursing, nursing education, and business development has supported the successful introduction and adoption of innovative healthcare technologies.